Literature DB >> 12908781

Clinical presentation of peritoneal mesothelioma.

Yair I Z Acherman1, Laura S Welch, Christina M Bromley, Paul H Sugarbaker.   

Abstract

AIM: To describe the clinical presentation of peritoneal mesothelioma and its impact on survival.
METHODS: Data was collected from 51 patients with peritoneal mesothelioma treated at the Washington Cancer Institute. The demographic, clinical and pathologic information were analyzed.
RESULTS: Pain was the most common symptom (recorded in 33% of patients); increased abdominal girth occurred in 31%, increased abdominal girth and pain in 5%, and a new onset hernia in 12%. In an additional 14% of patients, a variety of other clinical findings led to the diagnosis. There was a statistically significant difference in survival by gender, weight loss and volume of disease.
CONCLUSIONS: Pain was the most common initial presenting symptom, with increased abdominal girth as a second. A more favorable prognosis occurred in women with a small disease volume.

Entities:  

Mesh:

Year:  2003        PMID: 12908781     DOI: 10.1177/030089160308900307

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  24 in total

1.  Clear cell mesothelioma presenting as an incarcerated abdominal hernia.

Authors:  Nelson G Ordóñez
Journal:  Virchows Arch       Date:  2005-07-14       Impact factor: 4.064

Review 2.  Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.

Authors:  Alfonso García-Fadrique; Akash Mehta; Faheez Mohamed; Sanjeev Dayal; Tom Cecil; Brendan J Moran
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 3.  Malignant peritoneal mesothelioma: a review.

Authors:  Joseph Kim; Shanel Bhagwandin; Daniel M Labow
Journal:  Ann Transl Med       Date:  2017-06

Review 4.  Splenic localization of the peritoneal mesothelioma: case report and literature revue.

Authors:  Dario D'Abbicco; Angelica Conversano; Barbara Rita Epifania; Rocco Indellicato; Antonio Margari
Journal:  Updates Surg       Date:  2011-06-10

5.  A Rare Complication of Diffuse Malignant Peritoneal Mesothelioma: Spontaneous Ileal Perforation.

Authors:  Orhan Kalaycı; Güven Barış Cansu; Bengür Taşkıran; Özlem Eren
Journal:  Indian J Surg Oncol       Date:  2019-04-06

Review 6.  Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

Authors:  Terence C Chua; Tristan D Yan; David L Morris
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

Review 7.  Malignant peritoneal mesothelioma: a review.

Authors:  Glenn Broeckx; Patrick Pauwels
Journal:  Transl Lung Cancer Res       Date:  2018-10

8.  The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.

Authors:  Aatur D Singhi; Alyssa M Krasinskas; Haroon A Choudry; David L Bartlett; James F Pingpank; Herbert J Zeh; Alyssa Luvison; Kimberly Fuhrer; Nathan Bahary; Raja R Seethala; Sanja Dacic
Journal:  Mod Pathol       Date:  2015-10-23       Impact factor: 7.842

Review 9.  Peritoneal mesothelioma: a review.

Authors:  Alessio Bridda; Ilaria Padoan; Roberto Mencarelli; Mauro Frego
Journal:  MedGenMed       Date:  2007-05-10

10.  Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma.

Authors:  Terence C Chua; Peng Yao; Javed Akther; Lawrence Young; Shisan Bao; Ushma Samaraweera; Tristan D Yan; David L Morris
Journal:  Pathol Oncol Res       Date:  2009-04-29       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.